Basics Royalty Pharma plc IPO Date: June 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $13.77B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 1.20% Avg Daily Range (30 D): $0.35 | 1.08% Avg Daily Range (90 D): $0.35 | 1.09% Institutional Daily Volume Avg Daily Volume: 2M Avg Daily Volume (30 D): 3.98M Avg Daily Volume (90 D): 3.95M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 110 Avg Trade Size (Sh.) (90 D): 108 Institutional Trades Total Inst.Trades: 7,838 Avg Inst. Trade: $4.45M Avg Inst. Trade (30 D): $7.55M Avg Inst. Trade (90 D): $6.09M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 6 Market Closing Trades Avg Closing Trade: $12.37M Avg Closing Trade (30 D): $18.13M Avg Closing Trade (90 D): $19.86M Avg Closing Volume: 350.45K         News May 16, 2025 @ 8:30 PM Royalty Pharma Completes the Acquisition of Its Ex... Source: Globe Newswire May 12, 2025 @ 8:15 PM Royalty Pharma Announces Shareholder Approval of i... Source: Globe Newswire Apr 21, 2025 @ 8:15 PM Royalty Pharma Declares Second Quarter 2025 Divide... Source: Globe Newswire Feb 12, 2025 @ 2:39 PM Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lo... Source: Vandana Singh Jan 10, 2025 @ 12:15 PM Royalty Pharma Announces Transformative Step in Co... Source: Globe Newswire Financials   TTM Q1 2025 Q3 2024 Basic EPS $.55 $1.22 Diluted EPS $.55 $1.21 Revenue $ $ 568.25M $ 564.69M Gross Profit $ $ $ Net Income / Loss $ $ 433.43M $ 806.36M Operating Income / Loss $ $ 534.18M $ 735.07M Cost of Revenue $ $ $ Net Cash Flow $ $ 158.69M $ -814.59M PE Ratio     Splits Oct 15, 2010:   1:4